Compared to mice that received control siRNA injection at day 7, mice that received PTX3 siRNA injection at day 7 showed larger numbers of BrdU/CD31‐double positive cells (newly emerged endothelial cells) at day 21 after stroke onset (Figure 4B). Here, PTX3 is linked to stroke disorder.